CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Quest Patent Research Corp  (QPRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

QPRC's Revenue Growth by Quarter and Year

Quest Patent Research's Revenue results by quarter and year




QPRC Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - - 0.07 0.18
III Quarter September 0.01 0.58 0.71 0.15
II Quarter June 6.21 0.64 0.33 0.06
I Quarter March 0.86 0.02 0.16 0.12
FY   7.08 1.24 1.27 0.51



QPRC Revenue third quarter 2018 Y/Y Growth Comment
Quest Patent Research Corp reported drop in Revenue in the third quarter by -98.96% to $ 0.01 millions, from the same quarter in 2017.
The fall in the third quarter Quest Patent Research Corp's Revenue compares unfavorably to the Company's average Revenue jump of 40.53%.

Looking into third quarter results within Biotechnology & Drugs industry 80 other companies have achieved higher Revenue growth. While Quest Patent Research Corp' s Revenue meltdown of -98.96% ranks overall at the positon no. 3029 in the third quarter.




QPRC Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - -61.11 % -48.57 %
III Quarter September -98.96 % -18.31 % 373.33 % -54.55 %
II Quarter June 870.31 % 93.94 % 450 % 0 %
I Quarter March 4200 % -87.5 % 33.33 % -42.86 %
FY   - -2.36 % 149.02 % -

Financial Statements
Quest Patent Research's third quarter 2018 Revenue $ 0.00 millions QPRC's Income Statement
Quest Patent Research's third quarter 2017 Revenue $ 0.00 millions Quarterly QPRC's Income Statement
New: More QPRC's historic Revenue Growth >>


QPRC Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - -90.14 % 20 %
III Quarter September -99.9 % -9.38 % 115.15 % 150 %
II Quarter June 622.09 % 3100 % 106.25 % -50 %
I Quarter March - -71.43 % -11.11 % -65.71 %
FY (Year on Year)   - -2.36 % 149.02 % -




Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #81
Healthcare Sector #397
Overall #3029

Revenue Y/Y Growth Statistics
High Average Low
269.61 % 40.53 % -68.59 %
(March 31, 2014)   (March 31, 2016)
Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #81
Healthcare Sector #397
Overall #3029
Revenue Y/Y Growth Statistics
High Average Low
269.61 % 40.53 % -68.59 %
(March 31, 2014)   (March 31, 2016)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Quest Patent Research's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
33052.28 % 1811.9 % -99.9 %
(Mar 31 2018)  


QPRC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2018 Quest Patent Research Corp reported fall in Revenue from the previous quarter by -99.9% to $ 0.01 millions, from $ 6.21 millions released a quarter before.

If you evaluate recent shortcoming in the III. Quarter 2018, you suppose to take into consideration, that usually III. Quarter Revenue appear to be softer then in the preciding period, Ananya Banerjee , market consultant added.

Within Biotechnology & Drugs industry 117 other companies have achieved higher Revenue quarter on quarter growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is 3754.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #118
Healthcare Sector #501
Overall #3754
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #118
Healthcare Sector #501
Overall #3754
Revenue Q/Q Growth Statistics
High Average Low
33052.28 % 1811.9 % -99.9 %
(Mar 31 2018)  


QPRC's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2018 Quest Patent Research Corp disclosed fall in Revenue from the previous quarter by -99.9% to $ 0.01 millions, from $ 6.21 millions declared in the previous qaurter.

This is not important concern, as Revenue generally gravitate to slow in this quarter Ananya Banerjee , market consultant wrote.

Within Biotechnology & Drugs industry 117 other companies have achieved higher Revenue quarter on quarter growth. While Quest Patent Research's Revenue growth quarter on quarter, overall rank is 3754.


Quest Patent Research's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Revenue 12 Months Ending $ 7.07 $ 7.64 $ 2.07 $ 1.23 $ 1.30
Y / Y Revenue Growth (TTM) 442.61 % 434.07 % 84.96 % -2.58 % -5.05 %
Year on Year Revenue Growth Overall Ranking # 54 # 52 # 253 # 2994 # 62
Seqeuential Revenue Change (TTM) -7.48 % 268.68 % 68.32 % -5.49 % -8.94 %
Seq. Revenue Growth (TTM) Overall Ranking # 3029 # 21 # 68 # 3597 # 3453




Cumulative Revenue growth Comment
Quest Patent Research saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 442.61% year on year, to $ 7 millions if the fiscal year would have ended in Sep 30 2018.
Quest Patent Research's trailing twelve months Revenue growth was higher than company's average 146.27% and higher than 434.07% growth in Jun 30 2018.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 52 to 54.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
40.53 %
-68.59 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 81
Healthcare Sector # 18
Overall # 54

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
146.27 %
-77.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 81
Sector # 397
S&P 500 # 3029
Cumulative Revenue growth Comment
Quest Patent Research saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 442.61% year on year, to $ 7 millions if the fiscal year would have ended in Sep 30 2018.
Quest Patent Research's trailing twelve months Revenue growth was higher than company's average 146.27% and higher than 434.07% growth in Jun 30 2018.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 52 to 54.

Revenue TTM Q/Q Growth Statistics
High Average Low
269.61 %
40.53 %
-68.59 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 81
Healthcare Sector # 18
Overall # 54

Revenue TTM Y/Y Growth Statistics
High Average Low
1161.68 %
146.27 %
-77.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 81
Sector # 397
S&P 500 # 3029




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QPRC's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for QPRC's Competitors
Revenue Growth for Quest Patent Research's Suppliers
Revenue Growth for QPRC's Customers

You may also want to know
QPRC's Annual Growth Rates QPRC's Profitability Ratios QPRC's Asset Turnover Ratio QPRC's Dividend Growth
QPRC's Roe QPRC's Valuation Ratios QPRC's Financial Strength Ratios QPRC's Dividend Payout Ratio
QPRC's Roa QPRC's Inventory Turnover Ratio QPRC's Growth Rates QPRC's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2018
U.s. Stem Cell, Inc. -0.17 %$ -0.175 millions
Tg Therapeutics, Inc. -0.25 %$ -0.252 millions
Alphatec Holdings, Inc. -0.42 %$ -0.420 millions
Natures Sunshine Products Inc -0.53 %$ -0.530 millions
Chemocentryx, Inc. -0.60 %$ -0.598 millions
Capital Senior Living Corp -1.42 %$ -1.422 millions
Anika Therapeutics, Inc. -1.46 %$ -1.460 millions
Heska Corp -1.51 %$ -1.505 millions
Quest Diagnostics Inc -2.18 %$ -2.175 millions
Luminex Corp -2.28 %$ -2.281 millions
Avinger Inc -2.46 %$ -2.463 millions
Invacare Corporation -2.53 %$ -2.530 millions
Lemaitre Vascular Inc -2.65 %$ -2.647 millions
Birner Dental Management Services Inc -2.72 %$ -2.723 millions
Shineco, Inc. -2.82 %$ -2.822 millions
Allergan Plc -3.05 %$ -3.046 millions
American Shared Hospital Services -3.10 %$ -3.100 millions
Diversicare Healthcare Services, Inc. -3.38 %$ -3.379 millions
Aac Holdings, Inc. -3.67 %$ -3.669 millions
Bausch Health Companies Inc. -3.74 %$ -3.740 millions
Mylan N.v. -4.17 %$ -4.175 millions
Hca Healthcare, Inc. -4.31 %$ -4.312 millions
Radnet, Inc. -4.42 %$ -4.418 millions
Cleveland Biolabs Inc -4.57 %$ -4.572 millions
Icu Medical Inc -4.68 %$ -4.681 millions
Ocular Therapeutix, Inc. -4.78 %$ -4.780 millions
Brookdale Senior Living Inc. -4.92 %$ -4.917 millions
Infusystem Holdings, Inc -5.18 %$ -5.180 millions
Opko Health, Inc. -5.19 %$ -5.192 millions
Endo International Plc -5.26 %$ -5.264 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AVDX's Profile

Stock Price

AVDX's Financials

Business Description

Fundamentals

Charts & Quotes

AVDX's News

Suppliers

AVDX's Competitors

Customers & Markets

Economic Indicators

AVDX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071